DHFR and non-Hodgkin lymphoma: Methotrexate (MTX) is an antifolate inhibitor of dihydrofolate reductase (DHFR) employed in the treatment of children with acute lymphoblastic anemia (ALL), non-Hodgkin’s lymphoma, and osteosarcoma.